Biography
Dr. Chiou conducts clinical trials investigating new therapies for inflammatory and genetic skin diseases, along with evaluating artificial intelligence-driven decision support approaches for skin cancer and melanoma detection. He is active in supporting institutional research informatics efforts pertinent to clinical research and clinical trials across Stanford Medicine.
Professional Summary
Education & Certifications
- Board Certification: American Board of Dermatology, Dermatology (2017)
- Chief Resident, Stanford Hospital and Clinics (2017)
- Residency: Stanford University Dermatology Residency (2017) CA
-
- Internship: Santa Clara Valley Medical Center Dept of Medicine (2014) CA
- MD, MBA, Harvard Medical School (2013)
- MPhil, University of Cambridge, Chemistry, by Research (2008)
- BS, Stanford University, Chemistry (2007)
Honors & Awards
- Gates Cambridge Scholarship, Gates Cambridge Trust (2007 - 2008)
- Medical Dermatology Career Development Award, Dermatology Foundation (2019 - 2021)
-
Memberships
- Augmented Intelligence Committee, American Academy of Dermatology (2023 - Present)
- Member, American Academy of Dermatology (2017 - Present)
-
Administrative Appointments
- Director of Clinical Research, Stanford Department of Dermatology (2024 - Present)
- Director of Value Based Care, Stanford Department of Dermatology (2021 - 2024)
- Director, Stanford Skin Innovation and Interventional Research Group (SIIRG), Stanford Department of Dermatology (2019 - Present)
-
- Faculty Champion for Clinical Research Transformation, Stanford Medicine (2023 - Present)
Publications
-
Reaction of Cl with CD4 excited to the second C-D stretching overtone
Martin, M. R., Brown, D. J. A., Chiou, A. S., & Zare, R. N. (2007). Reaction of Cl with CD4 excited to the second C-D stretching overtone. JOURNAL OF CHEMICAL PHYSICS, 126(4). -
PHYS 379-Effects of reagent vibrational excitation on the Cl+CD4 reaction
Martin, M. R., Brown, D. J. A., Chiou, A. S., & Zare, R. N. (2006). PHYS 379-Effects of reagent vibrational excitation on the Cl+CD4 reaction. AMER CHEMICAL SOC. -
Reaction products with internal energy beyond the kinematic limit result from trajectories far from the minimum energy path: An example from H+HBr -> H-2+Br
Pomerantz, A. E., Camden, J. P., Chiou, A. S., Ausfelder, F., Chawla, N., Hase, W. L., & Zare, R. N. (2005). Reaction products with internal energy beyond the kinematic limit result from trajectories far from the minimum energy path: An example from H+HBr -> H-2+Br. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 127(47), 16368–69. -
-
Tazarotene: randomized, double-blind, vehicle-controlled, and open-label concurrent trials for Basal cell carcinoma prevention and therapy in patients with Basal cell nevus syndrome.
Tang, J. Y., Chiou, A. S., Mackay-Wiggan, J. M., Aszterbaum, M., Chanana, A. M., Lee, W., … Epstein, E. H. (2014). Tazarotene: randomized, double-blind, vehicle-controlled, and open-label concurrent trials for Basal cell carcinoma prevention and therapy in patients with Basal cell nevus syndrome. Cancer Prevention Research , 7(3), 292–99. -
A fibrous papule with abundant CD34-immunoreactive ganglion-like multinucleated giant cells: a case report and review of the literature.
Schaberg, K. B., Chiou, A. S., Wang, K. C., & Egbert, B. M. (2015). A fibrous papule with abundant CD34-immunoreactive ganglion-like multinucleated giant cells: a case report and review of the literature. Dermatology Online Journal, 21(7). -
Localized bullous pemphigoid in a melanoma patient with dual exposure to PD-1 checkpoint inhibition and radiation therapy.
Hirotsu, K., Chiou, A. S., Chiang, A., Kim, J., Kwong, B. Y., & Pugliese, S. (2017). Localized bullous pemphigoid in a melanoma patient with dual exposure to PD-1 checkpoint inhibition and radiation therapy. JAAD Case Reports, 3(5), 404–6. -
Cutaneous Neonatal Lupus Arising in an Infant Conceived From an Oocyte Donation Pregnancy
Chiou, A. S., Sun, G., Kim, J., Wang, K. C.-K., & Marqueling, A. L. (2016). Cutaneous Neonatal Lupus Arising in an Infant Conceived From an Oocyte Donation Pregnancy. JAMA DERMATOLOGY, 152(7), 846–47. -
Advanced aging skin and itch: addressing an unmet need
Garibyan, L., Chiou, A. S., & Elmariah, S. B. (2013). Advanced aging skin and itch: addressing an unmet need. DERMATOLOGIC THERAPY, 26(2), 92–103. -
Tumor angiogenesis as a target for dietary cancer prevention.
Li, W. W., Li, V. W., Hutnik, M., & Chiou, A. S. (2012). Tumor angiogenesis as a target for dietary cancer prevention. Journal of Oncology, 2012, 879623-? -
Probing Neuroserpin Polymerization and Interaction with Amyloid-beta Peptides Using Single Molecule Fluorescence
Chiou, A., Haeggloef, P., Orte, A., Chen, A. Y., Dunne, P. D., Belorgey, D., … Klenerman, D. (2009). Probing Neuroserpin Polymerization and Interaction with Amyloid-beta Peptides Using Single Molecule Fluorescence. BIOPHYSICAL JOURNAL, 97(8), 2306–15. -
Distinguishing malignant from benign microscopic skin lesions using desorption electrospray ionization mass spectrometry imaging.
Margulis, K., Chiou, A. S., Aasi, S. Z., Tibshirani, R. J., Tang, J. Y., & Zare, R. N. (2018). Distinguishing malignant from benign microscopic skin lesions using desorption electrospray ionization mass spectrometry imaging. Proceedings of the National Academy of Sciences of the United States of America. -
Repeat patch testing in a patient with allergic contact dermatitis improved on dupilumab.
Zhu, G. A., Chen, J. K., Chiou, A., Ko, J., & Honari, G. (2019). Repeat patch testing in a patient with allergic contact dermatitis improved on dupilumab. JAAD Case Reports, 5(4), 336–38. -
Assessment of the Development of New Regional Dermatoses in Patients Treated for Atopic Dermatitis With Dupilumab.
Zhu, G. A., Chen, J. K., Chiou, A., Ko, J., & Honari, G. (2019). Assessment of the Development of New Regional Dermatoses in Patients Treated for Atopic Dermatitis With Dupilumab. JAMA Dermatology. -
Distinguishing malignant from benign microscopic skin lesions using desorption electrospray ionization mass spectrometry imaging
Margulis, K., Chiou, A. S., Aasi, S. Z., Tibshirani, R. J., Tang, J. Y., & Zare, R. N. (2018). Distinguishing malignant from benign microscopic skin lesions using desorption electrospray ionization mass spectrometry imaging. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 115(25), 6347–52. -
Angiodestructive lymphomatoid papulosis lasting more than 45years.
Lee, G. H., Bae, G. H., Rieger, K. E., Kim, Y. H., & Chiou, A. S. (2019). Angiodestructive lymphomatoid papulosis lasting more than 45years. JAAD Case Reports, 5(9), 767–69. -
Phase 2 Trial of a Neurokinin-1 Receptor Antagonist for the Treatment of Chronic Itch in Epidermolysis Bullosa Patients: A Randomized Clinical Trial.
Chiou, A. S., Choi, S., Barriga, M., Dutt-Singkh, Y., Solis, D. C., Nazaroff, J., … Tang, J. Y. (2019). Phase 2 Trial of a Neurokinin-1 Receptor Antagonist for the Treatment of Chronic Itch in Epidermolysis Bullosa Patients: A Randomized Clinical Trial. Journal of the American Academy of Dermatology. -
Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa.
Eichstadt, S., Barriga, M., Ponakala, A., Teng, C., Nguyen, N. T., Siprashvili, Z., … Tang, J. Y. (2019). Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa. JCI Insight, 4(19). -
Inflammatory alopecia in patients on dupilumab: a retrospective cohort study at an academic institution.
Zhu, G. A., Kang, K. J., Chen, J. K., Novoa, R. A., Brown, R. A., Chiou, A. S., … Honari, G. (2019). Inflammatory alopecia in patients on dupilumab: a retrospective cohort study at an academic institution. Journal of the European Academy of Dermatology and Venereology : JEADV. -
Dupilumab Treatment of Nummular Dermatitis: A Retrospective Cohort Study.
Choi, S., Zhu, G. A., Lewis, M. A., Honari, G., Chiou, A. S., Ko, J., & Chen, J. K. (2020). Dupilumab Treatment of Nummular Dermatitis: A Retrospective Cohort Study. Journal of the American Academy of Dermatology. -
Dupilumab for occupational irritant hand dermatitis in a nonatopic individual: A case report.
Zhu, G. A., Honari, G., Ko, J. M., Chiou, A. S., & Chen, J. K. (2020). Dupilumab for occupational irritant hand dermatitis in a nonatopic individual: A case report. JAAD Case Reports, 6(4), 296–98. -
An exploratory, open-label, investigator-initiated study of interleukin-17A (IL-17A) blockade in patients with moderate to severe papulopustular rosacea.
Kumar, A. M., Chiou, A. S., Shih, Y. H., Li, S., & Chang, A. L. (2020). An exploratory, open-label, investigator-initiated study of interleukin-17A (IL-17A) blockade in patients with moderate to severe papulopustular rosacea. The British Journal of Dermatology. -
Pernio-like eruption associated with COVID-19 in skin of color.
Daneshjou, R., Rana, J., Dickman, M., Yost, J. M., Chiou, A., & Ko, J. (2020). Pernio-like eruption associated with COVID-19 in skin of color. JAAD Case Reports, 6(9), 892–97. -
Bridging to a selective Janus kinase 1 inhibitor in severe atopic dermatitis: An instructive case with upadacitinib.
Nguyen, J., Chen, J. K., Honari, G., Pol-Rodriguez, M., Ko, J. M., & Chiou, A. S. (2021). Bridging to a selective Janus kinase 1 inhibitor in severe atopic dermatitis: An instructive case with upadacitinib. JAAD Case Reports, 7, 65–67. -
TrueImage: A Machine Learning Algorithm to Improve the Quality of Telehealth Photos.
Vodrahalli, K., Daneshjou, R., Novoa, R. A., Chiou, A., Ko, J. M., & Zou, J. (2021). TrueImage: A Machine Learning Algorithm to Improve the Quality of Telehealth Photos. Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing, 26, 220–31. -
A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa.
Tang, J. Y., Marinkovich, M. P., Lucas, E., Gorell, E., Chiou, A., Lu, Y., … Rudin, D. (2021). A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa. Orphanet Journal of Rare Diseases, 16(1), 175. -
Prevalence of Potentially Allergenic Ingredients in Products Labeled for Eczema Care.
Schwartz, B. L., Honari, G., Chiou, A. S., Ko, J., Sarin, K. Y., & Chen, J. K. (2021). Prevalence of Potentially Allergenic Ingredients in Products Labeled for Eczema Care. Journal of the American Academy of Dermatology. -
Histopathologic correlation of skin manifestations of multisystemic inflammatory syndrome in adults (MIS-A) associated with SARS-CoV-2 infection.
So, N. A., So, J., Centkowski, S., Rana, J., Aleshin, M., Kwong, B. Y., … Chiou, A. S. (2021). Histopathologic correlation of skin manifestations of multisystemic inflammatory syndrome in adults (MIS-A) associated with SARS-CoV-2 infection. JAAD Case Reports. -
Telehealth for Older Adults with Skin Disease: A Qualitative Exploration of Dermatologists' Experiences & Recommendations for Improving Care.
de Vere Hunt, I., van Egmond, S., Nava, V., Khodosh, R., Lester, J., Chiou, A. S., & Linos, E. (2021). Telehealth for Older Adults with Skin Disease: A Qualitative Exploration of Dermatologists' Experiences & Recommendations for Improving Care. The British Journal of Dermatology. -
A qualitative exploration of the experiences of itch for adults living with epidermolysis bullosa.
de Vere Hunt, I., Halley, M., Sum, K., Yekrang, K., Phung, M., Good, J., … Chiou, A. S. (1800). A qualitative exploration of the experiences of itch for adults living with epidermolysis bullosa. The British Journal of Dermatology. -
Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis: Analysis of Follow-up Data From the Measure Up 1 and Measure Up 2 Randomized Clinical Trials.
Simpson, E. L., Papp, K. A., Blauvelt, A., Chu, C.-Y. Y., Hong, H. C.-H., Katoh, N., … Guttman-Yassky, E. (2022). Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis: Analysis of Follow-up Data From the Measure Up 1 and Measure Up 2 Randomized Clinical Trials. JAMA Dermatology. -
A global, cross-sectional survey of patient-reported outcomes, disease burden, and quality of life in epidermolysis bullosa simplex.
So, J. Y., Fulchand, S., Wong, C. Y., Li, S., Nazaroff, J., Gorell, E. S., … Tang, J. Y. (2022). A global, cross-sectional survey of patient-reported outcomes, disease burden, and quality of life in epidermolysis bullosa simplex. Orphanet Journal of Rare Diseases, 17(1), 270. -
Disparities in dermatology AI performance on a diverse, curated clinical image set.
Daneshjou, R., Vodrahalli, K., Novoa, R. A., Jenkins, M., Liang, W., Rotemberg, V., … Chiou, A. S. (2022). Disparities in dermatology AI performance on a diverse, curated clinical image set. Science Advances, 8(32), eabq6147. -
Asymptomatic, Microscopic Hematuria in Epidermolysis Bullosa: A Single Center Retrospective Case Series.
Betancourt, N. J., Sum, K., Gorell, E. S., Tang, J. Y., & Chiou, A. S. (2022). Asymptomatic, Microscopic Hematuria in Epidermolysis Bullosa: A Single Center Retrospective Case Series. Journal of the American Academy of Dermatology. -
Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa.
So, J. Y., Nazaroff, J., Iwummadu, C. V., Harris, N., Gorell, E. S., Fulchand, S., … Chiou, A. S. (2022). Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa. Orphanet Journal of Rare Diseases, 17(1), 377. -
Evaluation of diagnosis diversity in artificial intelligence datasets: a scoping review.
Chen, M. L., Rotemberg, V., Lester, J. C., Novoa, R. A., Chiou, A. S., & Daneshjou, R. (2023). Evaluation of diagnosis diversity in artificial intelligence datasets: a scoping review. The British Journal of Dermatology, 188(2), 292–294. -
Development and Clinical Evaluation of an Artificial Intelligence Support Tool for Improving Telemedicine Photo Quality.
Vodrahalli, K., Ko, J., Chiou, A. S., Novoa, R., Abid, A., Phung, M., … Daneshjou, R. (2023). Development and Clinical Evaluation of an Artificial Intelligence Support Tool for Improving Telemedicine Photo Quality. JAMA Dermatology. -
Best Practices for Clinical Skin Image Acquisition in Translational Artificial Intelligence Research.
Phung, M., Muralidharan, V., Rotemberg, V., Novoa, R. A., Chiou, A. S., Sadée, C. Y., … Daneshjou, R. (2023). Best Practices for Clinical Skin Image Acquisition in Translational Artificial Intelligence Research. The Journal of Investigative Dermatology, 143(7), 1127–1132. -
Dupilumab significantly improves sleep in adults with atopic dermatitis: results from the 12-week placebo-controlled period of the 24-week phase 4 randomized double-blinded placebo-controlled DUPISTAD study.
Merola, J. F., Chiou, A. S., During, E., Costanzo, A., Foley, P., Alfalasi, A., … Ozturk, Z. E. (2023). Dupilumab significantly improves sleep in adults with atopic dermatitis: results from the 12-week placebo-controlled period of the 24-week phase 4 randomized double-blinded placebo-controlled DUPISTAD study. The British Journal of Dermatology. -
Association between yearlong air pollution and moderate-severe atopic dermatitis: A United States cross-sectional claims analysis.
Trinh, P., Allerup, J. A., Li, S., Ko, J., Chen, J., Linos, E., & Chiou, A. S. (2023). Association between yearlong air pollution and moderate-severe atopic dermatitis: A United States cross-sectional claims analysis. JAAD International, 13, 4–6. -
Development of a digital tool for home-based monitoring of skin disease for older adults.
van Egmond, S., Cai, Z. R., Nava, V., Joy de Vere Hunt, I., Rapaport, B. R., Ko, J., … Linos, E. (2023). Development of a digital tool for home-based monitoring of skin disease for older adults. Skin Health and Disease, 3(5), e235. -
Noninvasive Detection of Skin Cancer by Imprint Desorption Electrospray Ionization Mass Spectrometry Imaging.
Meng, Y., Chiou, A. S., Aasi, S. Z., See, N. A., Song, X., & Zare, R. N. (2023). Noninvasive Detection of Skin Cancer by Imprint Desorption Electrospray Ionization Mass Spectrometry Imaging. Analytical Chemistry. -
Adult-onset inflammatory linear verrucous epidermal nevus successfully treated with intralesional steroid.
Johnson, A. N., Sum, K., Rieger, K. E., Chiou, A. S., & Li, D. J. (2024). Adult-onset inflammatory linear verrucous epidermal nevus successfully treated with intralesional steroid. JAAD Case Reports, 46, 5–7. -
Parental E-Cigarette Use and Pediatric Atopic Dermatitis.
Youn, G. M., Sarin, K. Y., Chiou, A. S., Chen, J. K., & Honari, G. (2024). Parental E-Cigarette Use and Pediatric Atopic Dermatitis. JAMA Dermatology. -
Single-Lesion Skin Cancer Risk Stratification Triage Pathway.
Chen, Y., Gui, H., Yao, H., Adu-Brimpong, J., Javitz, S., Golovko, V., … Chiou, A. S. (2024). Single-Lesion Skin Cancer Risk Stratification Triage Pathway. JAMA Dermatology. -
Evaluation of antipruritic effects of serlopitant, a neurokinin 1 receptor antagonist, in patients with epidermolysis bullosa: A phase 2 randomized controlled trial.
Okata-Karigane, U., Pathmarajah, P., Gorell, E. S., Sum, K., Yekrang, K., Phung, M., … Chiou, A. S. (2024). Evaluation of antipruritic effects of serlopitant, a neurokinin 1 receptor antagonist, in patients with epidermolysis bullosa: A phase 2 randomized controlled trial. Journal of the European Academy of Dermatology and Venereology : JEADV. -
Improved sleep parallels improvements in atopic dermatitis signs, symptoms, and quality of life in adult patients treated with dupilumab: 24-week results from the DUPISTAD study.
Merola, J. F., Chiou, A. S., During, E., Foley, P., Wu, J., Ardeleanu, M., & Ozturk, Z. E. (2024). Improved sleep parallels improvements in atopic dermatitis signs, symptoms, and quality of life in adult patients treated with dupilumab: 24-week results from the DUPISTAD study. Journal of the American Academy of Dermatology. -
DDI-2: A Diverse Skin Condition Image Dataset Representing Self-Identified Asian Patients.
Chang, C. T., Pathmarajah, P., Allerup, J., Jafry, S., Yekrang, K., Mitchell, D. C., … Chiou, A. S. (2024). DDI-2: A Diverse Skin Condition Image Dataset Representing Self-Identified Asian Patients. The Journal of Investigative Dermatology.
-
Tazarotene: randomized, double-blind, vehicle-controlled, and open-label concurrent trials for Basal cell carcinoma prevention and therapy in patients with Basal cell nevus syndrome.
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
- A Neurokinin-1 Receptor Antagonist for the Treatment of Pruritus in Patients With Epidermolysis Bullosa
- Study to Evaluate Adverse Events and Change in Disease Activity With Oral Tablets of Upadacitinib in Adult Participants With Non-Segmental Vitiligo
- 12-week Study of NFX-179 Gel in Subjects With Epidermal Nevi
- Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)
- Neurokinin-1 Receptor Antagonist for the Treatment of Itch in EB Patients
- A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
- SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"
Practice Locations
Stanford Dermatology Clinic in Livermore Livermore, CA
Livermore, CAStanford Dermatology Clinic in Livermore
1133 E Stanley Blvd, Ste 111
Livermore , CA 94550
Make An Appointment More Clinic Information Getting HereStanford Health Care Tri-Valley Pleasanton, CA
Pleasanton, CAStanford Health Care Tri-Valley
5565 W Las Positas Blvd
Pleasanton , CA 94588
Make An Appointment More Clinic Information Getting HereGeneral Dermatology Clinic in Redwood City Redwood City, CA
Redwood City, CAGeneral Dermatology Clinic in Redwood City
450 Broadway Street, Pavilion B 4th Floor
Redwood City , CA 94063
Make An Appointment More Clinic Information Getting HereImportant Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Patient Reviews
(264 reviews)
View More Patient Reviews
Referring Physicians
PHYSICIAN HELPLINE
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records